Aleafia Health Launches High Potency CBD 50 Cannabis Oil

IndustryPRwire – Aleafia Health is pleased to announce the launch of high potency CBD 50 oils, further strengthening the Company’s growing line of cannabis products for wellness oriented consumers. It will be sold to adult-use consumers as Symbl High CBD 50, and to medical patients as Emblem CBD 50.

Geoff Benic Aleafia Health CEO Commented “The commercialization of our business is fully underway with Aleafia Health’s third major product release in the last month, CBD 50 formulas are differentiated and highly sought after formats in both the medical and adult-use markets which further reinforces our cannabis extract market leadership position.”

CBD sales to medical patients commenced today, with product shipments to the adult-use market expected later this month. Highlights include:

  • High Potency: CBD 50, with 50 mg per millilitre of CBD oil, provides greater consumer and patient convenience and has more than twice the potency of traditional high CBD oils.
  • Full Spectrum: Formulated and produced at Aleafia Health’s product innovation centre in Paris, Ont., CBD 50 features full spectrum, supercritical CO2 extracted CBD oils which preserve the cannabis plant’s properties.
  • Repeatable Effects: Emblem CBD 50 is strain-specific, providing patients with a consistent product experience.
  • High Market Demand: Not widely available in Canada currently, high potency CBD oils are frequently requested by the Company’s patients and physicians, along with provincial government adult-use wholesalers.

Related Posts

Subscribe Our Newsletter